(Q46797788)

25 December 2017

title

Eformoterol n-of-1 trials in chronic obstructive pulmonary disease poorly reversible to salbutamol (English)

1 reference

25 December 2017

chronic obstructive pulmonary disease

main subject

rac-salbutamol

0 references

1 reference

2

1 reference

25 December 2017

author name string

B J Smith

1

1 reference

25 December 2017

A J Veale

3

1 reference

25 December 2017

H J McElroy

4

1 reference

25 December 2017

D Veljkovic

5

1 reference

25 December 2017

L Saccoia

6

1 reference

25 December 2017

publication date

1 January 2004

1 reference

25 December 2017

Chronic Respiratory Disease

published in

1 reference

25 December 2017

volume

1

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

63-69

1 reference

25 December 2017

Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1479972304CD028OA

Caring for elderly dependents: effects on the carers' quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1479972304CD028OA

Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1479972304CD028OA

Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1479972304CD028OA

Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1479972304CD028OA

An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1479972304CD028OA

A measure of quality of life for clinical trials in chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1479972304CD028OA

Assessing the minimal important difference in symptoms: a comparison of two techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1479972304CD028OA

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1479972304CD028OA

Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1479972304CD028OA

Health status measurement in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1479972304CD028OA

Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1479972304CD028OA

Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1479972304CD028OA

10.1191/1479972304CD028OA

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017